≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Carcinoma in situ of skin of lower limb, including hip

DOID EFO Endpoint Browser

CD2_INSITU_SKIN_LOWERLIMB

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D04.7&
  • Hospital discharge: ICD-9 — 2327
  • Cause of death: ICD-10 — D04.7&
  • Cause of death: ICD-9 — 2327

2 out of 7 registries used, show all original rules.

630

4. Check minimum number of events

None

630

5. Include endpoints

None

630

6. Filter based on genotype QC (FinnGen only)

630

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D04
Name in latin
Carcinoma in situ cutis pelvis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 630 371 259
Unadjusted period prevalence (%) 0.12 0.13 0.11
Median age at first event (years) 74.73 73.77 76.10

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
553
Matched controls
5530
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
+∞
323.0
552
*
L57.0
ICD-10 Finland
Actinic keratosis
22.7
218.7
383
499
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
21.3
199.2
339
382
TQW99
NOMESCO Finland
Other minor procedure on skin
28.0
177.2
255
164
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
27.7
129.2
182
96
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
40.5
103.9
131
42
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
9.7
94.6
220
352
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
91.1
89.7
98
13
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
21.5
88.0
133
80
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
67.5
87.6
100
18
R23.8
ICD-10 Finland
Other and unspecified skin changes
7.2
85.6
256
589
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
16.1
81.3
138
112
ZXC20
NOMESCO Finland
Use of chemical agents
23.8
79.7
116
61
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
9.2
76.1
177
269
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
9.8
73.7
163
226
ZXC50
NOMESCO Finland
Cryotherapy
14.3
73.1
130
116
D06BB10
ATC
imiquimod; topical
12.3
67.5
129
133
ZXC15
NOMESCO Finland
Use of photodynamic technique
22.4
65.7
97
52
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
108.7
62.4
67
7
ZQZ00
NOMESCO Finland
Treatment of several skin areas
62.4
61.5
71
13
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
13.1
60.9
112
105
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
8.3
60.9
148
233
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
12.8
57.6
107
102
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
88.8
57.3
63
8
S18
ICPC
Laceration/cut
4.3
55.3
378
1863
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
31.6
54.2
72
26
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
14.1
49.6
87
72
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
17.3
38.9
62
40
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
14.2
38.7
67
53
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
90.8
38.4
42
5
Z2221
NOMESCO Finland
Medical doctor
3.5
38.3
247
1041
L82
ICD-10 Finland
Seborrhoeic keratosis
3.5
31.0
174
638
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
13.5
30.2
53
43
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
5.0
30.0
105
248
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
28.6
29.7
40
15
127
Kela drug reimbursment
Transplant complication
18.7
29.3
45
26
Z94.0
ICD-10 Finland
Kidney transplant status
24.5
29.2
41
18
ZZR00
NOMESCO Finland
Flap of skin
8.8
29.1
64
81
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
67.8
28.2
32
5
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
37.2
27.8
35
10
ZZA00
NOMESCO Finland
Split skin graft
8.1
26.8
62
85
E0000UV
ATC
NA
2.6
24.5
272
1503
XQ848
NOMESCO Finland
Dermatological photography
8.0
23.8
55
75
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
20.7
23.8
35
18
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
5.7
23.6
71
140
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
9.9
22.8
46
50
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
26.3
22.0
30
12
L04AA01
ATC
[U] ciclosporin; systemic
13.1
21.2
37
30
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
25.4
21.1
29
12
ZXE00
NOMESCO Finland
One hour or less
2.4
21.0
271
1579
SPAT1153
SPAT
Removal of sutures
2.4
21.0
252
1417
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
23.5
20.6
29
13
S21
ICPC
Skin texture symptom/complaint
3.1
20.4
126
477
S29
ICPC
Skin symptom/complaint other
2.8
20.3
155
674
WX002
NOMESCO Finland
Sedation and analgesia
2.6
20.0
177
838
8070/3-C44.7
ICD-O-3
Squamous cell carcinoma, NOS, of skin of lower limb and hip
+∞
19.9
19
*
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
30.2
19.8
26
9
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
12.0
19.8
36
32
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
22.6
19.7
28
13
L04AD01
ATC
ciclosporin; systemic
11.6
19.5
36
33
A12BA01
ATC
potassium chloride; oral
4.1
19.1
78
211
DHB00
NOMESCO Finland
Excision of lesion of external nose
15.6
19.1
31
21
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
18.8
192
980
Z3231
NOMESCO Finland
Registered nurse
2.4
18.6
214
1156
205
Kela drug reimbursment
Chronic hypertension
2.3
18.3
258
1539
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
34.2
18.1
23
7
QDA50
NOMESCO Finland
Cryotherapy of skin of lower limb
98.3
17.7
19
*
S77
ICPC
Malignant neoplasm of skin
9.8
17.4
35
38
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
16.6
17.2
27
17
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
7.1
16.7
41
62
A12AA04
ATC
calcium carbonate; oral
10.0
16.6
33
35
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.8
16.6
42
66
R4110
NOMESCO Finland
Physiotherapy
2.3
16.4
196
1068
TQW80
NOMESCO Finland
Local dermatologic skincare
7.7
16.0
37
51
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.6
16.0
131
583
L04AA06
ATC
mycophenolic acid; systemic
10.9
15.9
30
29
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
8.6
15.7
34
42
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.4
15.7
164
832
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
9.4
15.6
32
36
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
4.7
15.3
53
122
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
15.3
252
1571
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
13.7
14.8
25
19
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.2
14.8
57
146
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
14.6
308
2112
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
14.5
260
1669
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
9.0
14.4
30
35
XQ845
NOMESCO Finland
Dermatoscopy
8.1
14.0
31
40
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
20.7
13.9
20
10
7151
FHL
Kidney transplantation
143.4
13.5
14
*
A98
ICPC
Health maint/preventive medicine
3.3
13.3
520
4577
WX110
NOMESCO Finland
Local anesthesy
2.0
13.2
358
2659
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
13.2
259
1703
Z3226
NOMESCO Finland
Physiotherapist
2.3
12.9
139
707
D06BX02
ATC
ingenol mebutate; topical
6.6
12.6
32
51
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.1
12.6
34
59
D07AB08
ATC
desonide; topical
2.8
12.6
86
340
D07AC01
ATC
betamethasone; topical
2.0
12.5
211
1296
137
Kela drug reimbursment
Uraemia requiring dialysis
13.6
12.5
21
16
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.4
12.1
61
197
A11CC03
ATC
alfacalcidol; systemic
5.3
11.9
36
72
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
12.1
11.9
21
18
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.8
11.6
38
83
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.8
11.6
49
137
ZXA05
NOMESCO Finland
Left side
2.0
11.6
196
1200
L04AX01
ATC
azathioprine; systemic
4.6
11.5
40
93
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.8
11.5
32
58
C44.79
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including hip or other unspecified histology
+∞
11.5
11
*
J01DB01
ATC
cefalexin; oral
2.1
11.4
447
3698
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
20.5
11.2
16
8
D02AE01
ATC
carbamide; topical
3.2
10.9
58
196
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
5.1
10.7
33
68
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.6
10.6
83
356
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
14.6
10.5
17
12
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
10.4
281
2005
L85.80
ICD-10 Finland
Hudhorn
16.4
10.4
16
10
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
23.9
10.3
14
6
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
6.4
10.3
26
42
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
8.4
9.9
21
26
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
4.5
9.9
34
79
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
20.5
9.8
14
7
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
9.8
9.8
19
20
S08
ICPC
Skin colour change
3.3
9.6
49
160
XF404
NOMESCO Finland
Ambulatory ECG
2.4
9.6
82
368
B07.9
ICD-10 Finland
Verruca simplex
4.7
9.6
32
72
C44.82
ICD-10 Finland
Overall spinocellular carcinoma of the skin
101.7
9.4
10
*
L04AA05
ATC
[U] tacrolimus; systemic
+∞
9.4
9
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.5
9.4
43
130
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
9.3
130
731
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.9
9.2
20
26
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
8.5
9.1
19
23
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
9.1
137
791
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
15.9
9.1
14
9
B03XA01
ATC
erythropoietin; parenteral
7.8
8.7
19
25
L17
ICPC
Foot/toe symptom/complaint
1.8
8.7
171
1083
40199
ICD-8 Finland
Essential benign hypertension
4.4
8.6
30
71
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.9
8.6
34
91
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
16.6
8.6
13
8
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
16.6
8.6
13
8
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
28.0
8.5
11
*
Z71.8
ICD-10 Finland
Other specified counselling
1.9
8.5
131
763
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
8.4
98
506
D03.5
ICD-10 Finland
Melanoma in situ of trunk
13.0
8.4
14
11
S01GX01
ATC
cromoglicic acid; ophthalmic
2.1
8.4
98
510
QCA30
NOMESCO Finland
Electrocoagulation of skin of upper limb
+∞
8.4
8
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
8.2
173
1115
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
8.2
121
690
C44.01
ICD-10 Finland
Basocellular carcinoma of the lip skin
33.9
8.1
10
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
8.1
58
237
RJ420
NOMESCO Finland
NA
22.4
8.0
11
5
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
7.9
110
612
DAB10
NOMESCO Finland
Partial excision of auricle
13.3
7.9
13
10
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
8.6
7.9
16
19
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.0
7.9
45
160
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.7
7.8
208
1442
DAB00
NOMESCO Finland
Excision of lesion of auricle
7.6
7.7
17
23
B01AB05
ATC
enoxaparin; parenteral
1.7
7.7
202
1393
J01MA02
ATC
ciprofloxacin; systemic
1.7
7.6
236
1703
L01BB01
ATC
NA
25.4
7.6
10
*
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
25.4
7.6
10
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
7.6
188
1269
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.8
7.6
48
182
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
7.5
132
800
Z49.0
ICD-10 Finland
Preparatory care for dialysis
7.3
7.5
17
24
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.8
7.5
141
874
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.4
7.5
61
269
RJ120
NOMESCO Finland
NA
81.1
7.4
8
*
RJ512
NOMESCO Finland
NA
81.1
7.4
8
*
R4120
NOMESCO Finland
Occupational therapy
2.9
7.4
43
155
E000001
ATC
NA
1.9
7.3
119
701
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
+∞
7.3
7
*
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
6.4
7.3
18
29
E000007
ATC
NA
3.3
7.3
35
111
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
16.0
7.3
11
7
M25.5
ICD-10 Finland
Pain in joint
1.8
7.2
144
908
WX320
NOMESCO Finland
Spinalanesthesy
1.8
7.2
150
961
N18.0
ICD-10 Finland
End-stage renal disease
6.2
7.1
18
30
S82
ICPC
Naevus/mole
2.1
7.1
79
402
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
7.1
7.0
16
23
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
7.0
57
247
C02CA01
ATC
prazosin; oral
4.7
7.0
22
48
H02AB04
ATC
methylprednisolone; systemic
2.0
6.9
97
539
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
6.9
155
1013
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.2
6.9
34
110
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
14.0
6.9
11
8
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
14.0
6.9
11
8
D02AX
ATC
Other emollients and protectives
4.0
6.9
26
68
D04
ICD-10 Finland
Carcinoma in situ of skin
16.9
6.8
10
6
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.5
6.7
22
50
C44.70
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including the hip without histology
22.8
6.7
9
*
N02BE01
ATC
paracetamol; systemic, rectal
1.9
6.7
483
4330
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.0
6.7
36
125
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.0
6.6
35
120
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
6.6
182
1262
ZXA00
NOMESCO Finland
Right side
1.7
6.5
184
1280
L28
ICPC
Limited function/disability (L)
1.8
6.5
125
776
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
4.8
6.5
20
43
C44.69
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including shoulder other or unspecified histology
70.6
6.4
7
*
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
14.5
6.4
10
7
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
14.5
6.4
10
7
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
14.5
6.4
10
7
C03AA03
ATC
hydrochlorothiazide; oral
2.0
6.4
84
456
N02AX02
ATC
tramadol; systemic, rectal
1.6
6.4
242
1817
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
6.4
95
543
D22
ICD-10 Finland
Melanocytic naevi
3.9
6.4
24
63
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
4.4
6.3
21
49
L12
ICPC
Hand/finger symptom/complaint
2.0
6.3
81
435
TQW40
NOMESCO Finland
Remowal of suture of skin
2.4
6.3
50
217
WXQ44
NOMESCO Finland
Photodynamic therapy of lower limb
+∞
6.3
6
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
7.2
6.3
14
20
M05BA04
ATC
alendronic acid; oral
2.0
6.1
80
432
M48.0
ICD-10 Finland
Spinal stenosis
1.9
6.1
98
573
L43.9
ICD-10 Finland
Lichen planus, unspecified
5.0
6.1
18
37
C08CA02
ATC
felodipine; oral
1.9
6.1
87
487
L03
ICPC
Low back symptom/complaint
1.7
6.1
136
882
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
5.3
6.1
17
33
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
6.1
6.0
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
299
662
7.69
143.01
2.2
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
514
2051
9.18
129.28
5.3
2.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
137
255
6.59
73.64
1.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
337
1771
2.94
38.81
8.1
5.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
376
2333
2.52
27.74
9.2
5.4
%
0.7
0.6
1.12
352
2150
(3006504) Eosinophils/100 leukocytes in Blood
382
2394
2.51
27.48
9.2
5.3
%
2.6
2.8
1.36
356
2201
(3019069) Monocytes/100 leukocytes in Blood
382
2405
2.49
27.03
9.5
5.6
%
8.7
8.9
0.31
358
2221
(3024561) Albumin [Mass/volume] in Serum or Plasma
402
2636
2.45
25.31
5.4
4.3
g/l
34.0
34.4
0.81
363
2424
(3002030) Lymphocytes/100 leukocytes in Blood
381
2444
2.41
25.14
9.5
5.6
%
26.5
25.9
0.36
355
2238
(3018010) Neutrophils/100 leukocytes in Blood
377
2410
2.41
25.03
9.1
5.3
%
58.1
58.7
0.35
351
2224
(36304419) Bacteria [Presence] in Urine
282
1597
2.39
24.62
4.5
3.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
391
2559
2.39
24.32
8.6
5.1
e9/l
0.0
0.0
1.28
327
2194
(3030467) Casts [#/volume] in Urine by Automated count
290
1684
2.34
23.65
4.6
3.4
e6/l
0.3
0.5
1.75
224
1303
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
542
4176
3.13
23.22
10.1
7.4
u/l
80.7
80.0
0.15
512
3877
(3001604) Monocytes [#/volume] in Blood
386
2548
2.33
23.01
8.7
5.1
e9/l
0.7
0.6
0.58
327
2175
(3013115) Eosinophils [#/volume] in Blood
395
2647
2.32
22.52
8.9
5.3
e9/l
0.2
0.2
0.66
334
2295
(3002582) Erythrocytes [#/volume] in Urine
302
1812
2.28
22.47
4.6
3.6
e6/l
49.1
113.8
1.01
233
1421
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
339
2140
2.26
22.22
4.7
3.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
389
2602
2.29
22.10
8.8
5.3
e9/l
2.5
1.9
1.11
331
2263
(3018095) Leukocytes [#/volume] in Urine
330
2069
2.25
21.88
5.5
4.1
e6/l
118.9
143.1
0.18
238
1527
(3013650) Neutrophils [#/volume] in Blood by Automated count
429
3020
2.32
21.13
11.7
8.4
e9/l
4.1
4.3
0.93
374
2639
(4035726)
119
482
2.81
20.60
1.5
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
429
3050
2.27
20.18
10.0
6.3
mmol/l
1.2
1.2
0.34
358
2559
(3007853) Bacteria identified in Skin by Aerobe culture
144
653
2.56
19.87
2.3
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
403
2806
2.21
19.78
9.1
5.6
mmol/l
1.2
1.2
0.53
369
2514
(3021589) Normoblasts [#/volume] in Blood
344
2268
2.14
19.22
14.4
10.3
e9/l
0.0
0.0
0.00
273
1870
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
569
4647
3.32
19.18
26.5
17.0
ml/min/173m2
65.8
70.4
5.59
501
3844
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
186
967
2.31
18.85
3.8
3.2
e6/l
3.5
2.7
0.18
96
544
(3003458) Phosphate [Moles/volume] in Serum or Plasma
159
790
2.35
17.78
8.8
4.6
mmol/l
1.0
1.0
0.26
149
709
(40758558) Short blood count panel - Blood
228
1320
2.14
17.50
8.5
6.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
609
5282
5.59
16.87
32.1
21.6
mmol/l
4.0
4.0
0.78
600
5128
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
338
2287
2.03
16.78
2.6
2.2
nmol/l
83.1
80.4
0.97
300
1973
(3019550) Sodium [Moles/volume] in Serum or Plasma
608
5277
5.36
16.59
31.1
21.4
mmol/l
139.3
139.5
0.85
599
5128
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
373
2622
2.04
16.55
2.4
2.2
pmol/l
99.2
94.1
1.16
200
1310
(3002385) Erythrocyte distribution width [Ratio]
504
3974
2.34
16.44
33.3
21.9
%
14.1
14.0
0.62
496
3887
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
188
1031
2.17
16.41
3.6
3.0
e6/l
0.6
1.4
5.67
97
604
(3018418) pH of Serum or Plasma
289
1866
2.01
16.20
6.9
3.8
ph
7.4
7.4
0.20
52
359
(3009542) Hematocrit [Volume Fraction] of Blood
527
4247
2.47
16.16
31.1
19.7
%
38.7
37.9
1.71
360
2510
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
604
5234
4.73
16.15
15.8
11.3
u/l
22.9
23.0
0.13
577
4990
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
36
77
4.90
16.07
4.9
4.6
iu/ml
197.8
179.7
—
6
10
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
223
1326
2.06
15.59
2.8
2.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
612
5378
5.83
15.51
37.7
26.0
fl
92.4
91.8
2.63
607
5267
(3007461) Platelets [#/volume] in Blood
612
5379
5.82
15.49
37.8
26.1
e9/l
232.5
242.5
3.24
598
5213
(3026361) Erythrocytes [#/volume] in Blood
612
5380
5.81
15.46
37.8
26.1
e12/l
4.3
4.3
0.92
596
5199
(3035941) MCH [Entitic mass]
612
5380
5.81
15.46
37.6
26.0
pg
30.5
30.4
1.42
607
5268
(3010813) Leukocytes [#/volume] in Blood
612
5381
5.81
15.43
37.8
26.1
e9/l
7.2
6.9
0.93
597
5198
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
113
511
2.48
15.41
5.4
3.4
ng/l
103.4
86.0
1.33
98
429
(3026782) Osmolality of Urine
214
1261
2.06
15.28
3.9
3.1
mosm/kgh2o
541.2
537.8
0.09
190
1078
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
557
4647
2.71
15.11
5.6
5.0
mu/l
2.1
2.0
0.12
496
4109
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
584
4999
3.30
14.98
26.0
17.7
mg/l
26.7
26.6
0.03
499
4118
(3042936) Bacteria identified in Isolate by Culture
160
851
2.18
14.91
2.1
2.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
564
4748
2.79
14.77
7.2
6.7
mmol/mol
40.3
41.1
1.31
515
4280
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
139
707
2.24
14.42
4.2
3.8
u/l
243.9
246.4
0.09
134
661
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
109
503
2.41
14.16
2.3
2.2
u/l
29.6
29.1
0.10
94
413
(3021960) Folate [Moles/volume] in Serum or Plasma
250
1608
1.92
13.54
1.7
1.6
nmol/l
21.4
20.8
0.21
214
1333
(3013707) Erythrocyte sedimentation rate by Westergren method
487
3919
2.07
13.08
5.0
4.3
mm/h
15.7
15.1
0.27
436
3534
(3000850) Epithelial cells [#/volume] in Urine
211
1299
1.94
12.91
3.5
2.7
e6/l
4.6
5.7
0.88
191
1151
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
156
866
2.07
12.79
3.7
2.4
%
20.6
20.9
0.07
140
719
(3004789) Transferrin [Mass/volume] in Serum or Plasma
162
912
2.05
12.78
3.4
2.3
g/l
2.2
2.3
0.72
145
825
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
574
4961
2.77
12.63
6.0
5.5
mmol/l
2.4
2.6
6.26
514
4397
(3026493) Urate [Moles/volume] in Serum or Plasma
220
1384
1.91
12.54
3.3
2.8
umol/l
11344.6
9296.7
0.15
182
1138
(3044640) Blood type and Crossmatch panel - Blood
267
1787
1.86
12.54
3.1
2.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
467
3739
1.96
12.21
6.9
5.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
106
516
2.27
12.08
10.4
7.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
307
2169
1.81
11.90
3.7
2.7
ug/l
135.2
145.3
0.38
277
1929
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
76
324
2.53
11.63
1.6
1.8
g/l
1.4
1.6
1.32
69
286
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
388
2964
1.80
11.35
6.4
5.8
umol/l
12.5
11.6
0.96
373
2790
(3023368) Bacteria identified in Blood by Culture
262
1786
1.80
11.28
5.7
4.3
—
—
—
0
0
(3044889) 12 lead EKG panel
465
3762
1.90
11.20
5.1
4.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
166
985
1.93
11.08
3.6
2.3
umol/l
11.4
11.9
0.51
149
888
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
552
4765
2.28
10.79
5.2
4.7
mmol/l
1.5
1.5
0.08
488
4202
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
90
430
2.28
10.67
2.1
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
578
5107
2.60
10.40
22.5
17.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
155
917
1.92
10.36
3.1
3.0
mmol/l
0.8
0.8
0.44
145
850
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
536
4599
2.11
10.24
4.7
4.2
mmol/l
1.3
1.2
0.18
469
4008
(3009508) Creatinine [Moles/volume] in Urine
254
1758
1.75
10.09
4.2
3.1
mmol/l
6.1
6.8
1.78
208
1417
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
238
1623
1.75
9.93
2.5
2.2
mg/l
2.9
3.2
1.55
205
1351
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
562
4928
2.30
9.89
5.8
5.2
mmol/l
6.1
6.1
0.37
495
4335
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
553
4821
2.20
9.82
5.4
4.8
mmol/l
4.3
4.5
3.44
492
4289
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
155
936
1.87
9.66
3.8
3.2
ug/l
0.8
0.8
0.33
119
650
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
204
1340
1.77
9.64
1.7
1.6
mmol/l
1.3
1.3
0.48
176
1094
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
57
232
2.60
9.58
3.0
2.8
g/l
0.5
1.2
1.22
50
193
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
188
1208
1.79
9.56
4.6
4.2
ng/l
163.9
271.1
0.68
173
1056
(3017143) Hepatitis C virus Ab [Presence] in Serum
74
341
2.33
9.53
1.9
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
114
624
2.01
9.49
1.6
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
291
2130
1.68
9.17
4.3
3.3
mmol/l
2.4
2.4
1.79
250
1798
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
465
3860
1.78
9.12
4.3
4.0
pmol/l
15.0
15.2
0.80
400
3396
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
54
220
2.59
9.06
3.1
2.3
g/l
37.6
36.8
0.51
48
181
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
330
2509
1.66
8.89
4.5
4.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
341
2615
1.66
8.88
13.3
11.2
inr
1.4
1.3
0.13
81
718
(3013826) Glucose [Moles/volume] in Serum or Plasma
414
3350
1.69
8.66
6.4
4.7
mmol/l
6.7
6.8
0.55
399
3159
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
170
1092
1.76
8.52
2.2
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
246
1749
1.67
8.49
4.2
3.2
mg/l
146.3
328.3
0.84
160
1088
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
303
2281
1.63
8.28
2.6
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
114
653
1.91
8.26
3.9
3.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
289
2156
1.63
8.16
3.5
3.2
ng/l
2273.1
1616.4
1.31
246
1874
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
29
89
3.37
8.02
1.4
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
100
559
1.94
7.77
8.9
5.8
mmol/l
1.2
1.4
1.28
95
531
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
358
2842
1.60
7.62
3.3
3.0
u/l
60.9
52.1
0.62
332
2550
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
39
148
2.74
7.53
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
39
148
2.74
7.53
1.6
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
79
412
2.05
7.46
1.7
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
44
179
2.57
7.42
4.6
3.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
71
357
2.11
7.38
1.7
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
217
2.42
7.36
2.5
2.4
u/ml
0.4
0.4
0.17
27
122
(3020682) Albumin/Creatinine [Ratio] in Urine
252
1857
1.60
7.24
5.4
4.0
mg/mmol
11.8
8.2
0.58
160
1151
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
55
251
2.31
7.24
3.1
2.5
g/l
3.0
3.2
1.05
48
193
(3051611) Lipemic interference index of Serum or Plasma
23
68
3.47
6.75
5.2
3.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
273
2.20
6.70
3.0
2.4
g/l
3.7
3.7
0.05
48
189
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
274
2.19
6.64
3.0
2.4
g/l
7.6
7.5
0.05
50
194
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
274
2.19
6.64
3.0
2.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
184
1282
1.61
6.56
3.5
3.1
mmol/l
2.5
2.5
0.39
157
1119
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
15
6.76
6.33
1.7
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
124
788
1.71
6.28
2.1
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
56
274
2.15
6.25
2.6
3.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
49
228
2.25
6.18
3.8
3.9
mg/l
86.6
85.2
0.01
39
183
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
82
463
1.89
6.15
1.6
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
112
698
1.74
6.07
2.8
4.1
ug/l
11.5
32.5
0.89
91
591
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
49
230
2.23
6.06
3.8
3.9
mg/l
32.1
60.8
1.11
40
187
(3020630) Protein [Mass/volume] in Serum or Plasma
95
566
1.80
6.01
2.4
3.0
g/l
64.1
65.8
1.71
88
501
(3000492) Spirometry study
68
364
1.97
5.97
2.1
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
35
143
2.53
5.88
2.5
2.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
123
795
1.68
5.83
3.0
2.4
%
1.7
1.8
0.52
107
698
(1002224) Polysomnography panel
28
103
2.80
5.76
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
83
483
1.83
5.66
2.1
2.0
ug/g
160.2
171.4
0.08
62
366
(3037522) Nuclear Ab [Titer] in Serum
95
577
1.76
5.62
1.5
1.3
titre
510.0
463.4
0.12
24
140
(3021879) Hepatitis B virus core Ab [Presence] in Serum
46
220
2.18
5.45
1.6
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
95
588
1.72
5.26
1.4
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
127
850
1.62
5.22
1.4
1.5
g/l
3.0
2.6
0.42
63
454
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
97
611
1.69
5.03
3.3
2.5
umol/l
8.4
8.8
0.08
90
534
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
118
786
1.62
4.93
2.1
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
268
2126
1.45
4.93
4.4
3.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
94
593
1.69
4.85
4.1
2.5
e9/l
68.0
68.2
0.01
56
474
(40768446) Kidney Pathology biopsy report
8
7
11.55
4.79
1.4
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
42
206
2.11
4.70
3.8
2.8
g/l
0.2
0.2
0.12
20
63
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
18
58
3.17
4.67
1.2
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
37
174
2.20
4.60
1.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
29
123
2.42
4.55
1.6
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
32
142
2.32
4.55
1.8
1.8
e6/l
9302.5
20163.5
1.09
23
97
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
139
980
1.54
4.53
1.3
1.2
u/ml
0.9
1.4
0.82
20
227
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
213
1642
1.45
4.46
6.2
5.7
ug/l
3.4
3.7
0.11
187
1423
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
27
112
2.47
4.44
1.7
2.4
%
187.4
206.2
0.60
27
107
(3003338) MCHC [Mass/volume]
439
3863
1.45
4.35
34.9
24.1
g/l
329.7
330.6
1.23
434
3832
(3004588) Protein electrophoresis panel - Serum or Plasma
79
490
1.70
4.34
2.6
2.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
57
322
1.85
4.29
1.3
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
94
613
1.63
4.26
5.1
3.2
mmol/l
0.9
2.0
1.45
82
490
(3044941) Cell count panel - Synovial fluid
24
97
2.53
4.18
1.9
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
28
122
2.36
4.16
1.8
2.1
%
94.0
88.0
0.86
28
115
(3010144) Erythrocytes [#/volume] in Synovial fluid
15
47
3.24
4.08
1.3
1.4
e6/l
23551.3
172272.0
—
8
30
(3021788) Differential panel - Synovial fluid
27
117
2.37
4.07
1.8
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
57
329
1.81
4.02
11.2
8.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
110
756
1.55
4.00
1.3
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
115
799
1.54
3.98
9.8
5.9
mmol/l
104.5
104.1
0.33
115
780
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
155
1152
1.46
3.86
1.7
1.6
mg/l
3.0
1.4
0.79
112
903
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
24
101
2.43
3.86
1.6
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
42
223
1.95
3.83
2.2
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
28
127
2.26
3.82
1.9
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
28
127
2.26
3.82
1.6
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
147
2.17
3.81
1.6
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
24
102
2.41
3.78
6.9
2.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
314
2644
1.37
3.78
6.9
6.0
estimate
0.0
0.0
0.00
63
494
(40768806) Pleura Pathology biopsy report
22
90
2.50
3.75
1.5
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
195
1521
1.41
3.71
3.5
3.0
u/l
30.5
36.1
1.47
183
1443
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
44
240
1.90
3.71
2.4
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
123
2.25
3.66
1.4
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
20
80
2.55
3.58
1.6
1.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
9
7.85
3.56
11.3
13.2
mmol/l
4.6
6.3
—
7
9
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
16
57
2.85
3.54
1.3
1.2
u/l
52.2
49.7
0.09
11
41
(3009343) pH of Capillary blood
62
382
1.69
3.51
4.8
4.1
ph
7.4
7.4
1.47
13
41
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
171
1316
1.41
3.49
5.0
4.8
%
24.0
21.5
1.00
95
692
(3009261) Glucose [Presence] in Urine by Test strip
315
2677
1.35
3.47
4.8
4.5
estimate
0.0
0.0
0.50
62
489
(3011397) Hemoglobin [Presence] in Urine by Test strip
166
1274
1.41
3.43
3.7
4.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
42
232
1.87
3.43
2.5
2.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
64
2.70
3.42
1.6
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
310
2636
1.35
3.37
4.8
4.4
estimate
0.0
0.0
0.00
67
501
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
37
3.29
3.35
1.1
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
37
3.29
3.35
1.1
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
228
1853
1.36
3.32
2.6
2.1
u/l
176.3
251.4
0.78
213
1735
(3022217) INR in Platelet poor plasma by Coagulation assay
126
925
1.45
3.32
45.5
30.7
inr
1.6
1.4
—
7
100
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
62
389
1.66
3.29
4.9
4.0
kpa
5.2
5.2
0.19
56
361
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
91
2.35
3.20
1.2
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
21
91
2.35
3.20
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
18
73
2.51
3.15
1.6
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
90
624
1.52
3.14
2.6
3.2
ng/l
275.9
249.1
0.16
84
576
(3051651) Icteric interference index of Serum or Plasma
12
39
3.12
3.10
7.0
3.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
58
364
1.65
3.08
4.9
4.1
mmol/l
1.8
1.9
0.13
46
275
(3000093) Morphology [Interpretation] in Blood Narrative
16
62
2.62
3.06
1.1
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
19
81
2.39
3.01
1.6
1.3
e6/l
20158.3
102483.4
—
10
52
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
5
10.06
2.98
1.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
5
10.06
2.98
1.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
22
4.13
2.89
1.9
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
61
397
1.59
2.82
4.8
3.9
%
0.8
0.5
0.38
17
102
(3019309) Folate [Moles/volume] in Red Blood Cells
179
1433
1.35
2.80
2.0
1.8
nmol/l
1144.3
1212.9
0.39
125
1054
(3019230) Fractional oxyhemoglobin in Venous blood
23
111
2.11
2.76
3.1
1.8
%
62.5
58.4
0.27
23
111
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
92
2.21
2.70
4.7
3.2
%
51.9
60.8
1.78
20
92
(3003396) Base excess in Arterial blood by calculation
103
757
1.43
2.69
8.9
6.1
mmol/l
1.0
1.4
0.51
85
589
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
103
758
1.43
2.67
8.9
6.0
kpa
5.2
5.1
0.56
98
725
(3027801) Oxygen [Partial pressure] in Arterial blood
103
759
1.43
2.65
8.9
6.0
kpa
13.2
11.5
2.77
97
727
(3023199) Leukocytes [#/volume] in Pleural fluid
20
93
2.19
2.63
1.6
1.3
e6/l
913.1
1345.8
0.55
13
70
(3025159) Blasts/100 leukocytes in Blood
60
398
1.56
2.58
5.0
4.1
%
0.2
0.9
0.40
18
107
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
26
136
1.95
2.54
1.4
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
33
3.06
2.53
1.5
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
30
166
1.85
2.49
4.2
4.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
21
3.84
2.47
1.6
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
21
3.84
2.47
1.6
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
69
477
1.50
2.46
7.0
4.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
11
40
2.78
2.38
1.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
22
3.67
2.37
1.6
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
184
1.78
2.36
1.6
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
7
17
4.15
2.36
1.0
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
34
200
1.74
2.33
1.1
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
47
2.58
2.28
1.5
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
47
304
1.59
2.27
1.3
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
39
241
1.66
2.25
2.2
2.1
nmol/l
9.6
11.8
0.68
32
203
(3019150) Specific gravity of Urine by Refractometry
90
1188
0.72
2.25
5.0
4.9
kg/l
1.0
1.0
1.49
16
182
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
86
2.13
2.24
3.4
2.8
e9/l
3.4
4.7
2.61
18
86
(3021440) Promyelocytes/100 leukocytes in Blood
61
420
1.50
2.23
4.9
4.1
%
0.1
0.1
0.46
17
127
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
60
2.36
2.23
1.4
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
12
48
2.53
2.19
3.0
2.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
75
541
1.44
2.18
6.8
3.9
mmol/l
1.2
1.2
0.83
64
469
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
19
3.71
2.15
1.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
27
153
1.80
2.11
1.5
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
16
75
2.16
2.10
1.8
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
25
3.23
2.10
1.6
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
25
3.23
2.10
1.6
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
25
3.23
2.10
1.6
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
25
3.23
2.10
1.6
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
23
124
1.89
2.09
2.3
2.1
g/l
121.3
124.0
0.19
16
89
(4015189)
7
20
3.53
2.06
1.6
3.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
207
1755
1.27
2.04
2.8
2.4
u/l
56.6
56.9
0.04
188
1596
(3003327) Ova and parasites identified in Stool by Light microscopy
21
112
1.91
1.98
2.0
1.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
9
205
0.43
1.98
5.2
3.5
mmol/l
3.3
3.9
—
9
189
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
49
332
1.52
1.96
1.6
1.6
%
1.7
1.6
0.30
42
277
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
11
4.57
1.94
1.4
1.2
umol/l
61.2
53.4
—
5
11
(4034850)
7
172
0.40
1.93
10.4
12.9
—
—
—
0
0
(4094501)
23
128
1.83
1.92
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
58
2.27
1.92
1.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
43
285
1.55
1.90
5.1
4.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
22
3.21
1.88
1.7
1.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
22
3.21
1.88
1.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
28
2.88
1.86
1.1
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
23
130
1.80
1.84
1.1
1.2
—
30.3
—
0
5
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
40
263
1.56
1.84
3.7
2.9
u/ml
35.2
73.3
1.09
40
255
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
72
533
1.40
1.84
1.5
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
65
473
1.42
1.83
3.4
1.8
nmol/l
345.5
382.8
0.78
60
420
(3017181) Myelocytes/100 leukocytes in Blood
62
449
1.42
1.79
5.1
4.0
%
1.2
0.9
0.23
17
140
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
60
2.19
1.79
1.1
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
47
2.36
1.78
1.6
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
61
2.15
1.72
2.2
2.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
11
48
2.31
1.71
1.1
1.1
g/l
1.4
1.6
0.66
11
43
(3035637) Corticotropin [Mass/volume] in Plasma
10
42
2.40
1.68
2.4
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
15
76
2.00
1.65
1.2
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
14
3.59
1.62
1.0
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
25
152
1.67
1.59
3.6
2.6
ug/min
45.4
80.2
0.48
15
95
(3011288) Drugs identified in Urine by Screen method
6
20
3.02
1.58
3.0
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
50
2.22
1.57
1.6
1.5
—
—
—
0
0
(3019225) pH of Specimen
78
602
1.34
1.56
6.4
4.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
57
2.13
1.56
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
26
161
1.64
1.55
1.6
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
33
2.44
1.54
1.8
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
27
2.61
1.52
1.7
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
36
243
1.51
1.51
4.5
2.7
pmol/l
4.1
4.4
1.32
29
210
(1616796) Gas panel - Central venous blood
21
124
1.72
1.49
4.1
4.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
53
389
1.40
1.45
1.5
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
27
172
1.60
1.45
1.1
1.5
ug/g
287.7
268.0
0.17
12
100
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
22
2.74
1.43
1.0
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
81
1.87
1.41
1.7
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
23
2.62
1.37
1.0
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
42
2.16
1.34
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
42
2.16
1.34
1.2
1.1
—
—
—
0
0
(44790047)
11
54
2.06
1.33
1.9
1.4
—
—
—
0
0
(44790049)
11
54
2.06
1.33
1.9
1.4
—
—
—
0
0
(44790048)
11
54
2.06
1.33
1.9
1.4
—
—
—
0
0
(44806118)
11
54
2.06
1.33
1.9
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
34
2.37
1.29
1.1
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
34
2.37
1.29
1.6
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
6
134
0.44
1.29
1.5
3.3
u/ml
30.5
2720.1
—
6
125
(21494434) Karyotype in Bone marrow
12
62
1.95
1.28
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
48
2.10
1.28
1.1
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
44
2.06
1.27
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
35
2.30
1.27
1.6
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
27
396
0.67
1.25
4.0
3.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
20
123
1.65
1.25
1.1
1.2
—
2.8
—
0
16
(3027456) Digoxin [Moles/volume] in Serum or Plasma
31
212
1.49
1.25
3.6
3.4
nmol/l
0.7
0.9
1.78
24
169
(40767503) Oxygen content in Capillary blood by calculation
21
131
1.62
1.25
2.8
2.4
%
15.3
15.2
0.01
15
56
(3027008) Opiates [Presence] in Urine
8
36
2.24
1.24
1.6
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
36
2.24
1.24
1.6
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
132
1123
1.22
1.23
1.3
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
19
2.64
1.22
2.0
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
19
2.64
1.22
2.0
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
19
2.64
1.22
1.0
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
22
140
1.59
1.21
3.8
4.3
mmol/l
2.7
3.0
0.22
14
90
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
20
125
1.62
1.19
1.1
1.2
—
9.6
—
0
23
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
26
2.32
1.19
1.5
1.5
g/l
1.0
0.9
—
6
26
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
90
738
1.26
1.18
1.2
1.2
u/ml
13.7
11.2
0.12
16
238
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
50
2.02
1.17
2.1
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
36
0.00
1.14
0.0
4.6
—
—
—
0
0
(4281824)
11
58
1.91
1.12
1.1
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
8
40
2.01
1.12
1.4
1.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
40
2.01
1.12
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
40
2.01
1.12
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
40
2.01
1.12
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
41
1.96
1.09
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
41
1.96
1.09
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
41
1.96
1.09
1.0
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
105
1.64
1.07
1.0
1.2
—
3.4
—
0
7
(3000330) Specific gravity of Urine by Test strip
24
346
0.68
1.05
7.8
4.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
182
2033
0.85
1.04
5.9
4.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
34
2.07
1.03
1.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
83
1.70
1.02
1.1
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
18
115
1.58
1.00
1.2
1.2
—
634.0
—
0
5
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
49
1.85
0.99
1.1
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
53
419
1.29
0.95
3.3
2.9
ml/min/173m2
49.7
53.6
0.33
27
176
(40768441) Liver Pathology biopsy report
7
37
1.90
0.94
1.1
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
64
520
1.26
0.93
1.3
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
60
736
0.80
0.92
9.4
9.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
194
1.41
0.89
1.3
1.2
—
—
—
0
0
(3036603) Volume of Urine
6
29
2.08
0.89
1.0
1.5
—
1766.7
—
0
7
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
111
1.55
0.88
1.1
1.2
—
—
—
0
0
(3020891) Body temperature
17
251
0.67
0.86
4.5
4.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
12
72
1.68
0.85
1.2
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
65
1.70
0.82
1.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
46
1.75
0.82
1.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
32
1.88
0.82
1.0
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
32
1.88
0.82
2.0
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
32
1.88
0.82
1.0
1.6
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
8
47
1.71
0.81
1.3
1.4
—
57.1
—
0
7
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
262
2433
1.13
0.80
4.6
4.2
ng/l
31.3
51.1
0.87
210
1908
(3013512) EKG study
199
1817
1.14
0.79
4.9
4.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
33
1.83
0.79
1.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
98
1.54
0.79
1.6
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
48
1.68
0.79
1.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
48
1.68
0.79
1.6
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
48
1.68
0.79
1.6
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
21
148
1.43
0.78
1.3
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.0
—
1.1
—
0
16
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
71
598
1.21
0.77
2.3
2.6
ug/l
8.1
6.5
0.29
55
508
(3017732) Neutrophils [#/volume] in Blood
41
324
1.28
0.77
3.0
3.2
e9/l
4.3
4.0
0.25
25
222
(3004451) EKG impression Narrative
6
34
1.77
0.76
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
18
124
1.46
0.76
1.4
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
2.0
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
90
780
1.18
0.72
1.2
1.2
iu/ml
61.0
39.4
0.29
23
249
(40768793) Breast Pathology biopsy report
19
134
1.43
0.72
1.4
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
24
319
0.74
0.70
5.5
3.8
%
48.3
46.6
0.10
24
313
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
43
1.63
0.67
4.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
111
1.45
0.66
1.5
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
28
1.79
0.66
1.2
3.9
u/l
201.0
238.0
—
5
28
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
7
44
1.60
0.65
1.0
1.0
—
2.3
—
0
12
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
44
1.60
0.65
1.0
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
112
1.44
0.64
2.9
2.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
104
1.45
0.63
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
101
0.59
0.62
1.5
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
43
520
0.81
0.62
4.6
3.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
22
0.00
0.59
0.0
3.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
22
0.00
0.59
0.0
3.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
72
1.54
0.59
2.1
2.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
23
175
1.33
0.59
1.4
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
113
0.62
0.58
2.0
2.6
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.6
—
52.3
—
0
15
(4027681)
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
35
1.72
0.58
1.8
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
35
1.72
0.58
2.0
2.0
—
—
—
0
0
(4024509)
8
54
1.49
0.57
2.0
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
127
1396
0.89
0.57
1.9
1.8
pmol/l
417.3
10503137.7
0.80
93
1114
(3045414) Leukocytes [Presence] in Urine
29
230
1.27
0.56
2.3
2.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
62
1.46
0.53
1.1
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
66
1.52
0.52
1.2
1.2
nmol/l
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
97
0.61
0.52
1.5
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
201
0.74
0.49
8.2
5.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
80
712
1.14
0.49
5.4
4.8
%
36.4
33.2
1.86
53
441
(3011648) Oxygen content in Venous blood
7
45
1.56
0.49
1.1
1.4
%
12.2
10.8
—
7
45
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
49
1.43
0.46
1.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
49
1.43
0.46
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
156
1.29
0.45
2.6
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
50
1.40
0.45
1.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
56
1.43
0.42
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
49
426
1.16
0.42
1.8
1.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
57
1.41
0.42
1.5
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
25.4
—
0
5
(4146454)
8
61
1.32
0.39
1.8
2.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
41
354
1.17
0.39
2.7
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
108
995
1.10
0.39
5.5
4.7
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
0.2
—
0
12
(3030981) Hyaline casts [#/volume] in Urine by Automated count
26
312
0.83
0.38
5.3
3.0
e6/l
0.4
0.2
0.28
26
305
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
66
1.37
0.38
4.6
4.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
36
1.39
0.38
1.8
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
36
1.39
0.38
6.2
17.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
36
1.39
0.38
1.8
1.4
—
—
—
0
0
(4062490)
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
70
1.29
0.36
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
90
1.34
0.36
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
99
1.32
0.35
1.4
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
42
1.43
0.35
1.2
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
73
1.38
0.34
2.7
4.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
44
1.37
0.34
1.2
1.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
15
118
1.28
0.33
1.0
1.1
—
17.3
—
0
6
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
46
1.31
0.33
1.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
141
0.78
0.29
3.4
2.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
76
1.32
0.28
1.2
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
85
1.30
0.28
1.7
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
86
1.28
0.26
1.1
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
75
0.66
0.26
4.2
6.6
mmol/l
6.0
7.2
—
5
58
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
105
1.24
0.25
1.5
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
76
1.19
0.24
1.1
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
96
1.25
0.24
2.2
2.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
97
1.24
0.23
1.5
1.3
—
—
—
0
0
(4306422)
5
39
1.28
0.23
1.4
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
5
42
1.19
0.21
1.8
1.9
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.3
—
0
6
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
12
0.00
0.21
0.0
5.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
14
0.00
0.20
0.0
1.6
—
4.3
—
0
6
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
6
49
1.23
0.20
1.0
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
49
1.23
0.20
1.0
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
50
1.20
0.19
5.0
3.7
umol/l
294.0
353.2
—
6
45
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
62
1.13
0.17
2.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
63
1.11
0.17
2.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
63
1.11
0.17
2.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
63
1.11
0.17
2.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
63
1.11
0.17
2.0
1.4
—
—
—
0
0
(4010399)
41
379
1.09
0.16
1.6
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
138
1331
1.05
0.16
4.1
3.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
144
1484
0.96
0.14
5.5
4.6
estimate
0.0
0.0
0.00
61
476
(3019060) Gas panel - Arterial blood
43
458
0.93
0.13
3.4
4.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
12
104
1.16
0.12
1.2
1.3
e6/l
31.7
1300.5
—
6
83
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
12
104
1.16
0.12
1.1
1.2
e6/l
3.7
4.2
—
6
81
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
85
1.18
0.12
1.3
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
135
1389
0.96
0.12
6.1
4.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
25
271
0.92
0.11
1.7
1.8
ug/l
0.5
2.7
1.30
19
231
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
13
115
1.13
0.10
1.3
1.2
mg/l
480.5
510.5
0.18
13
107
(3004716) Salmonella sp identified in Stool by Organism specific culture
19
208
0.91
0.10
1.1
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
5
44
1.14
0.10
1.6
2.1
ug/l
4.9
3.5
—
5
38
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
45
1.11
0.10
1.2
1.2
mmol/l
6.7
7.6
—
5
34
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
45
1.11
0.10
1.0
1.2
—
103.6
—
0
7
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
58
1.03
0.08
3.3
2.8
u/ml
19.0
56.5
—
6
58
(3006270) Folate [Moles/volume] in Blood
5
60
0.83
0.08
2.0
1.2
nmol/l
401.4
352.7
—
5
51
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
64
1.09
0.08
2.0
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
164
0.91
0.08
1.8
1.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
67
1.05
0.08
1.7
2.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
10
89
1.13
0.07
1.5
1.9
%
88.8
89.7
—
10
89
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
177
1.08
0.06
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
178
1.07
0.05
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
29
278
1.05
0.04
1.5
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
180
1.06
0.04
1.1
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
102
1.08
0.03
1.7
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
221
1.04
0.03
1.3
1.1
iu/ml
150.8
133.5
—
9
81
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
113
1.06
0.02
1.6
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
106
1.04
0.00
1.3
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
102
0.98
0.00
1.4
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
17.3
—
822.9
—
0
7
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
20.1
—
1467.4
—
0
7
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
65
0.92
0.00
1.5
1.6
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
15.1
—
0
5
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
98
0.92
0.00
1.1
1.5
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
80
1.00
0.00
3.8
2.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
65
0.92
0.00
1.0
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
7.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
85
0.94
0.00
1.3
1.6
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
7.5
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_SKIN_LOWERLIMB – Carcinoma in situ of skin of lower limb, including hip

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).